IL6 and stroke disorder: In accordance with the hypothesis that IL-6 trans-signaling is detrimental, while the classic one may exert protective effects, specific inhibition of trans-signaling mediators (i.e., using the chimeric protein sgp130Fc) may represent an interesting strategy for stroke therapy [69].